About Proteome SciencesProteome Sciences.
About Proteome SciencesProteome Sciences, a global leader in applied proteomics, uses high sensitivity proprietary technologies to detect biomarkers. Since its inception in 1994, Proteome Sciences has discovered a large number of novel protein biomarkers in key human diseases. PS Biomarker Services provides ISO 9001: 2008 accredited facilities in Frankfurt, Germany, with proprietary isobaric and isotopic Tandem Mass Day for protein biomarkers and reference materials with isotope dilution mass spectrometry discovery. Highly multiplexed assays can be developed rapidly and are suitable for screening hundreds of candidate biomarkers in validation studies. Assays for validated biomarkers for immunoassay development are transmitted. Proteome Sciences, in Cobham, with offices in London and Frankfurt, offers outsourced proteomics services and proprietary biomarkers to pharmaceutical, biotechnology and diagnostics companies..
Disease categories, including oncology, hematology, neurology, cardiology, infectious diseases, endocrinology, respiratory, gastroenterology, urology and immunology. Society early phase units offer fully validated analytical methods, capabilities,broad scope of cellular and soluble biomarker analysis capabilities, and bioanalytical services for the qualitative and quantitative drug metabolite and biomarker analysis in a variety of matrices.. Christopher Pearce, Chief Executive of Proteome Sciences said:’We are very pleased to have PS biomarker Services selected by PAREXEL as a preferred provider of protein and peptide biomarker services, we believe that the current regulatory requirements for biomarkers in drug development and. Diagnosis with the need for fast, flexible and cost effective workflows have pegged led to specialist services are increasingly needed. (more…)